Member News
-
Zentek and Triera Biosciences Ltd. Achieve Positive Results Against Avian Influenza (H5N1) using Multivalent Aptamer Technology
May 06, 2024 (Source) — Zentek Ltd. (“Zentek” or the “Company”) (Nasdaq:ZTEK)(TSX-V:ZEN), announces that its wholly-owned subsidiary Triera…
-
Energy Fuels Announces Q1-2024 Results, Including Continued Net Income, Continued Successful Uranium Ramp-Up, Commissioning Rare Earth Oxides Production, and Steps to Secure World-Scale Sources of Heavy Mineral Sands and Monazite
Conference Call and Webcast on May 6, 2024 May 03, 2024 (Source) — Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) (“Energy…
-
Zentek Announces Board and Management Changes
May 03, 2024 (Source) — Zentek Ltd. (“Zentek” or the “Company”) (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property development and commercialization company, announces…
-
FendX Announces First Real-World Performance Testing Site for REPELWRAP(TM) Film at Award Winning Giulietta Restaurant
Nanotechnology testing results will be used to continue to move towards large scale commercial production May 03, 2024…
-
-
Xcite Resources Provide Update on Beaver River Uranium Project
May 02, 2024 (Source) — Xcite Resources Inc. has received the results from a data compilation on the Beaver…
-
F3 Announces Revised Bought Deal Private Placement for Gross Proceeds of C$9.0 Million
May 02, 2024 (Source) — F3 Uranium Corp. (TSXV: FUU) (OTCQB: FUUFF) (“F3 Uranium” or the “Company”) is pleased…
-
Coeptis Therapeutics Announces Poster Data Presentation at American Society of Gene & Cell Therapy (ASGCT) 27th Annual Meeting
May 02, 2024 (Source) — Coeptis Therapeutics Holdings, Inc. (Nasdaq: COEP) (the “Company” or “Coeptis”), a biopharmaceutical company developing…